ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

Regional Groups: Why 15 Were Not Among Those Funded; Cancer Regional Studies Review Committee Chartered

July 2, 1982

Regulatory Agencies: FDA Regulation Of Tobacco Signed by President Clinton

September 6, 1996

Core Grants Limit Formula Must Wait On Profiles

January 27, 1978

In Brief: Antman, Chabner Vie For ASCO President-Elect; Irwin Krakoff Is 1993 Karnofsky Lecturer

January 8, 1993

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

Ohio Plans To Build Four New Cancer Centers With $140 Million Bond Issue If Voters Approve

February 21, 1975